Research ArticleBasic Science Investigation
Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu and Sumitaka Hasegawa
Journal of Nuclear Medicine October 2021, 62 (10) 1468-1474; DOI: https://doi.org/10.2967/jnumed.120.249300
Huizi Keiko Li
1Radiation and Cancer Biology Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;
Yukie Morokoshi
1Radiation and Cancer Biology Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;
Satoshi Kodaira
2Radiation Measurement Research Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;
Tamon Kusumoto
2Radiation Measurement Research Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;
Katsuyuki Minegishi
3Targetry and Target Chemistry Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
Hiroaki Kanda
4Department of Pathology, Saitama Cancer Center, Saitama, Japan
Kotaro Nagatsu
3Targetry and Target Chemistry Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and
Sumitaka Hasegawa
1Radiation and Cancer Biology Group, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 10
October 1, 2021
Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu, Sumitaka Hasegawa
Journal of Nuclear Medicine Oct 2021, 62 (10) 1468-1474; DOI: 10.2967/jnumed.120.249300
Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu, Sumitaka Hasegawa
Journal of Nuclear Medicine Oct 2021, 62 (10) 1468-1474; DOI: 10.2967/jnumed.120.249300
Jump to section
Related Articles
Cited By...
- No citing articles found.